Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
68.00    0.60 (0.89%)
Bid:
67.80
Ask:
67.90
Spread: 0.10 (0.147%)
Market Cap: £600.73m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director/PDMR Shareholding

7 Apr 2021 11:27

RNS Number : 6880U
IP Group PLC
07 April 2021
 

FOR RELEASE ON

7 April 2021

 

IP Group plc - Director/PDMR share dealing & SAYE option exercise

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that it has been notified of the following transactions in ordinary shares of 2 pence each in the Company ("Shares") by Directors and other Persons Discharging Managerial Responsibilities ("PDMRs") on Thursday 1 April 2021:

 

- Greg Smith, Chief Financial Officer, transferred, via sale and purchase, 17,000 Shares into his ISA. Mr Smith sold Shares at 125.5 pence per share and bought Shares at 125.7 pence per share. Following the transfer, Mr Smith's beneficial interest in the Company remains unchanged at 339,403 Shares, representing 0.03% of the total issued share capital.

- Angela Leach, General Counsel and Company Secretary, bought 15,020 Ordinary Shares into her ISA at 125.8 pence per share. Following the purchase, Ms Leach's beneficial interest in the Company is now 274,272 Shares, representing 0.03% of the total issued share capital.

- Dr Mark Reilly, Managing Partner Technology, exercised options under the Group's 2017 Save As You Earn plan ("SAYE") to buy 6,315 Shares at 114 pence per share. Following satisfaction of the options, Mr Reilly's beneficial interest in the Company will be 46,645 Shares, representing

 

Shares in issue

At the date of this announcement, the Company continues to have 1,062,353,734 ordinary shares in issue.

The following notifications, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, provide further details:

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Sale and purchase of Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

Sale

£1.255

17,000

Purchase

£1.257

17,000

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

Price(s)

Volume(s)

Aggregated total

Sale

£1.255

17,000

£21,336

Purchase

£1.257

17,000

£21,369

f)

Date of the transaction

Sale: 1 April 2021Purchase: 1 April 2021

g)

Place of the transaction

London

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Reilly

2

Reason for the notification

a)

Position/status

PDMR Managing Partner, Technology

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Exercise of an option to acquire Ordinary Shares under the Group's 2017 SAYE.

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Mark Reilly

£1.14

6,315

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

6,315

Price: £1.14

£7,200

f)

Date of the transaction

1 April 2021

g)

Place of the transaction

London

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Angela Leach

2

Reason for the notification

a)

Position/status

PDMR - General Counsel & Company Secretary

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Angela Leach

£1.2583

15,020

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

15,020

Price: £1.2583

£18,900

f)

Date of the transaction

1 April 2021

g)

Place of the transaction

London

 

 

 

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Greg Smith, Chief Financial OfficerAngela Leach, Company Secretary

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUAPCUPGGUM
Date   Source Headline
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.